Product Program year 2025 Source: CMS Open Payments

Cusa Clarity

Device Neuro Critical Care

PDI 10381780126232

Open in the dashboard

General payments

$348,485

5,533 payments

Research payments

$0

0 payments

Through program year 2025, $348,485 in general payments and $0 in research payments were reported against Cusa Clarity (Neuro Critical Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $77,649 1,205
2024 General $53,270 1,118
2023 General $72,812 1,026
2022 General $85,479 1,111
2021 General $59,275 1,073

Breakdown

Who paid General payments · program years 2021–2025
  1. Integra LifeSciences Corporation $348,485 5,533 payments
Top recipients General payments · program year 2025
  1. Lynn Kowalski Gynecologic Oncology · Las Vegas, NV $9,450 12% · 3 payments
  2. De Ette Vasques Gynecologic Oncology · Fort Worth, TX $1,798 2% · 3 payments
  3. Gerald Grant Neurological Surgery · Stanford, CA $1,700 2% · 1 payment
  4. Michael Kim Neurological Surgery · Orange, CA $1,580 2% · 24 payments
  5. Ramin Javahery Neurological Surgery · Long Beach, CA $1,028 1% · 16 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurological Surgery $35,619 47% · 364 practitioners
  2. Gynecologic Oncology Obstetrics & Gynecology $13,419 18% · 31 practitioners
  3. Physician Assistant $6,260 8% · 100 practitioners
  4. Surgery $2,819 4% · 30 practitioners
  5. Physician Assistant, Surgical Physician Assistant $1,891 2% · 41 practitioners

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $13,946 18% · 100 recipients
  2. New York $13,783 18% · 134 recipients
  3. Nevada $9,474 12% · 2 recipients
  4. Texas $8,340 11% · 133 recipients
  5. Missouri $3,737 5% · 48 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,533 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record